LEUKOTRIENES AND SENSORY INNERVATION IN BLOOD-AQUEOUS BARRIER DISRUPTION IN THE DOG

被引：15

作者：

WARD, DA

FERGUSON, DC

KASWAN, RL

GREEN, K

机构：

[1] Department of Small Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, Georgia

[2] Department of Physiology and Pharmacology, University of Georgia College of Veterinary Medicine, Athens, Georgia

[3] Department of Physiology, Department of Endocrinology, Medical College of Georgia, Augusta, Georgia

[4] Department of Urban Practice, College of Veterinary Medicine, University of Tennessee, Knoxville

来源：

JOURNAL OF OCULAR PHARMACOLOGY | 1992年 / 8卷 / 01期

关键词：

D O I：

10.1089/jop.1992.8.69

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

The effect of a specific 5-lipoxygenase inhibitor, PF5901 (5% in corn oil), on disruption of the blood-aqueous barrier (BAB) in the dog was investigated using a unilateral mild paracentesis model. BAB breakdown was quantitated using anterior chamber fluorophotometry. Fluorescence in the eyes of the PF5901 group was not statistically significantly different (P>0.05) from that in the vehicle group. A tendency towards greater fluorescein concentrations was noted in the PF5901 treated eyes. It was concluded that leukotrienes are not important mediators of BAB disruption in this model and that leukotriene inhibitors may actually exacerbate disruption due to shunting of arachidonate metabolism towards the cyclooxygenase and/or epoxygenase pathways. In a second experiment, the effects of proparacaine and flurbiprofen were evaluated on blood-aqueous barrier disruption and pupil size following a more severe paracentesis. Flurbiprofen dampened both barrier disruption and the miotic response but proparacaine suppressed neither reaction, suggesting that, in the dog, prostaglandins are more important mediators of the ocular irritative response than are sensory neuropeptides.

引用

页码：69 / 76

页数：8

共 35 条

[11]

Unger W.G., Mediation of the ocular response to injury and irritation: Peptides versus prostaglandins, The Ocular Effects of Prostaglandins and Other Eicosanoids, pp. 293-328, (1989)

[12]

Stjernschantz J., Sears M., Stjernschantz I., Intraocular effects of substance P in the rabbit, Invest Ophthalmol Vis Sci, 20, pp. 53-60, (1981)

[13]

Ward D.A., Ferguson D.C., Kaswan R.L., Green K., Bellhorn R.W., Fluorophotometric evaluation of experimental blood-aqueous barrier disruption in the dog, Am J Vet Res, 52, pp. 1433-1437

[14]

Waltman S.R., Kaufman H.E., A new objective slit-lamp fluorophotometer, Invest Ophthalmol Vis Sci, 4, pp. 247-249, (1970)

[15]

Sanders D.R., Kraff M.C., Lieberman H.L., Peyman G.A., Tarabishy S., Breakdown and reestablishment of blood-aqueous barrier with implant surgery, Arch Ophthalmol, 100, pp. 588-590, (1982)

[16]

Salmon J.A., Inhibition of prostaglandin, thromboxane and leukotriene biosynthesis, Adv Drug Res, 15, pp. 111-167, (1986)

[17]

Krohne S.D.G., Vestre W.A., Effects of flunixin meglumine and dexamethasone on aqueous protein values after intraocular surgery in the dog, Am J Vet Res, 48, pp. 420-422, (1987)

[18]

Masferrer J.L., Murphy R.C., Pagano P.J., Dunn M.W., Laniado-Schwartzman M., Ocular effects of a novel cytochrome p-450 dependent arachidonic acid metabolite, Invest Ophthalmol Vis Sci, 30, pp. 454-460, (1989)

[19]

Woodward D.F., Ledgard S.E., Comparison of leukotrienes as conjunctival microvascular permeability factors, Ophthalmic Res, 17, pp. 318-320, (1985)

[20]

Woodward D.F., Ledgard S.E., Effect of LTD4 on conjunctival vasopermeability and blood-aqueous barrier integrity, Invest Ophthalmol Vis Sci, 26, pp. 481-485, (1985)

← 1 2 3 4 →